Masaru Matsuda - Net Worth and Insider Trading

Masaru Matsuda Net Worth

The estimated net worth of Masaru Matsuda is at least $2 Million dollars as of 2024-11-05. Masaru Matsuda is the See Remarks of Arcutis Biotherapeutics Inc and owns about 183,288 shares of Arcutis Biotherapeutics Inc (ARQT) stock worth over $2 Million. Details can be seen in Masaru Matsuda's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Masaru Matsuda has not made any transactions after 2024-08-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Masaru Matsuda

To

Masaru Matsuda Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Masaru Matsuda owns 2 companies in total, including Halozyme Therapeutics Inc (HALO) , and Arcutis Biotherapeutics Inc (ARQT) .

Click here to see the complete history of Masaru Matsuda’s form 4 insider trades.

Insider Ownership Summary of Masaru Matsuda

Ticker Comapny Transaction Date Type of Owner
HALO Halozyme Therapeutics Inc 2020-01-03 SVP & General Counsel
ARQT Arcutis Biotherapeutics Inc 2024-08-02 SVP and General Counsel

Masaru Matsuda Latest Holdings Summary

Masaru Matsuda currently owns a total of 1 stock. Masaru Matsuda owns 183,288 shares of Arcutis Biotherapeutics Inc (ARQT) as of August 2, 2024, with a value of $2 Million.

Latest Holdings of Masaru Matsuda

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARQT Arcutis Biotherapeutics Inc 2024-08-02 183,288 9.30 1,704,578

Holding Weightings of Masaru Matsuda


Masaru Matsuda Form 4 Trading Tracker

According to the SEC Form 4 filings, Masaru Matsuda has made a total of 8 transactions in Arcutis Biotherapeutics Inc (ARQT) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Arcutis Biotherapeutics Inc is the sale of 5,220 shares on August 2, 2024, which brought Masaru Matsuda around $47,084.

Insider Trading History of Masaru Matsuda

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Masaru Matsuda Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Masaru Matsuda Ownership Network

Ownership Network List of Masaru Matsuda

No Data

Ownership Network Relation of Masaru Matsuda

Insider Network Chart

Masaru Matsuda Owned Company Details

What does Halozyme Therapeutics Inc do?

Who are the key executives at Halozyme Therapeutics Inc?

Masaru Matsuda is the SVP & General Counsel of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Technical Officer Michael J. Labarre , director & President and CEO Helen Torley , and SVP & Chief Financial Officer Nicole Labrosse .

Halozyme Therapeutics Inc (HALO) Insider Trades Summary

Over the past 18 months, Masaru Matsuda made no insider transaction in Halozyme Therapeutics Inc (HALO). Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 280,000 shares made by Michael J. Labarre , a net sale of 200,000 shares made by Helen Torley , and a net sale of 49,881 shares made by Matthew L. Posard .

In summary, during the past 3 months, insiders sold 199,881 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 199,881 shares. During the past 18 months, 584,881 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 584,881 shares.

Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Halozyme Therapeutics Inc Insider Transactions

No Available Data

Masaru Matsuda Mailing Address

Above is the net worth, insider trading, and ownership report for Masaru Matsuda. You might contact Masaru Matsuda via mailing address: 11388 Sorrento Valley Road, San Diego Ca 92121.